Ophthalmology Drugs Market Report

Ophthalmology Drugs Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Jun 18, 2020
  • PAGES：214
  • REPORT CODE：GMM550557
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Ophthalmology Drugs market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 5.0% during the forecast period.

    This report presents the market size and development trends by detailing the Ophthalmology Drugs market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Ophthalmology Drugs market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Ophthalmology Drugs industry and will help you to build a panoramic view of the industrial development.

    Ophthalmology Drugs Market, By Type:

    • Lucentis (ranibizumab)

    • Eylea (aflibercept)

    • Avastin (bevacizumab)

    • Restasis (cyclosporine)

    • Alphagan (brimonidine tartrate)

    • Lumigan (bimatoprost)

    • Xalatan (latanoprost

    Ophthalmology Drugs Market, By Application:

    • Chorioretinitis

    • Choroiditis

    • Retinitis

    • Others

    Some of the leading players are as follows:

    • Regeneron

    • Roche

    • Allergan

    • Shire

    • Novartis

    • Mallinckrodt

    • Bayer

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Ophthalmology Drugs Market

    • 1.3 Market Segment by Type

      • 1.3.1 Lucentis (ranibizumab)

      • 1.3.2 Eylea (aflibercept)

      • 1.3.3 Avastin (bevacizumab)

      • 1.3.4 Restasis (cyclosporine)

      • 1.3.5 Alphagan (brimonidine tartrate)

      • 1.3.6 Lumigan (bimatoprost)

      • 1.3.7 Xalatan (latanoprost

    • 1.4 Market Segment by Application

      • 1.4.1 Chorioretinitis

      • 1.4.2 Choroiditis

      • 1.4.3 Retinitis

      • 1.4.4 Others

    • 1.5 Market Segment by Regions

      • 1.5.1 North America Ophthalmology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 Europe Ophthalmology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 Asia-Pacific Ophthalmology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 LAMEA Ophthalmology Drugs Consumption Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Ophthalmology Drugs Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Ophthalmology Drugs by Major Types

      • 3.4.1 Lucentis (ranibizumab)

      • 3.4.2 Eylea (aflibercept)

      • 3.4.3 Avastin (bevacizumab)

      • 3.4.4 Restasis (cyclosporine)

      • 3.4.5 Alphagan (brimonidine tartrate)

      • 3.4.6 Lumigan (bimatoprost)

      • 3.4.7 Xalatan (latanoprost

    4 Segmentation of Ophthalmology Drugs Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Ophthalmology Drugs by Major End-Users

      • 4.4.1 Chorioretinitis

      • 4.4.2 Choroiditis

      • 4.4.3 Retinitis

      • 4.4.4 Others

    5 Market Analysis by Major Regions

    • 5.1 Global Ophthalmology Drugs Production Analysis by Top Regions

    • 5.2 Global Ophthalmology Drugs Consumption Analysis by Top Regions

    • 5.3 Global Ophthalmology Drugs Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 North America Ophthalmology Drugs Production, Import, Consumption and Export Analysis

      • 5.3.2 Europe Ophthalmology Drugs Production, Import, Consumption and Export Analysis

      • 5.3.3 Asia Pacific Ophthalmology Drugs Production, Import, Consumption and Export Analysis

      • 5.3.4 LAMEA Ophthalmology Drugs Production, Import, Consumption and Export Analysis

    6 Product Circulation of Ophthalmology Drugs Market among Top Countries

    • 6.1 Top 5 Export Countries in Ophthalmology Drugs Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Ophthalmology Drugs Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Ophthalmology Drugs Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Ophthalmology Drugs Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Ophthalmology Drugs Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Ophthalmology Drugs Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. North America Ophthalmology Drugs Landscape Analysis

    • 7.1 North America Ophthalmology Drugs Landscape Analysis by Top Countries

      • 7.1.1 United States Ophthalmology Drugs Market Volume and Growth Rate

      • 7.1.2 Canada Ophthalmology Drugs Market Volume and Growth Rate

      • 7.1.3 Mexico Ophthalmology Drugs Market Volume and Growth Rate

    8. Europe Ophthalmology Drugs Landscape Analysis

    • 8.1 Europe Ophthalmology Drugs Landscape Analysis by Major Types

    • 8.2 Europe Ophthalmology Drugs Landscape Analysis by Major End-Users

    • 8.3 Europe Ophthalmology Drugs Landscape Analysis by Top Countries

      • 8.3.1 Germany Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.2 UK Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.3 France Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.4 Italy Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.5 Spain Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.6 Belgium Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.7 Poland Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.8 Russia Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.9 Turkey Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.10 Netherlands Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.11 Portugal Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.12 Denmark Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.13 Finland Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.14 Iceland Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.15 Norway Ophthalmology Drugs Market Volume and Growth Rate

      • 8.3.16 Sweden Ophthalmology Drugs Market Volume and Growth Rate

    • 8.4 Top 3 Players Profiles in Europe

    9 Asia Pacific Ophthalmology Drugs Landscape Analysis

    • 9.1 Asia Pacific Ophthalmology Drugs Landscape Analysis by Top Countries

      • 9.1.1 China Ophthalmology Drugs Market Volume and Growth Rate

      • 9.1.2 Japan Ophthalmology Drugs Market Volume and Growth Rate

      • 9.1.3 Australia and New Zealand (ANZ) Ophthalmology Drugs Market Volume and Growth Rate

      • 9.1.4 India Ophthalmology Drugs Market Volume and Growth Rate

      • 9.1.5 ASEAN Ophthalmology Drugs Market Volume and Growth Rate

      • 9.1.6 South Korea Ophthalmology Drugs Market Volume and Growth Rate

    10 LAMEA Ophthalmology Drugs Landscape Analysis

    • 10.1 LAMEA Ophthalmology Drugs Landscape Analysis by Top Countries

      • 10.1.1 GCC Countries Ophthalmology Drugs Market Volume and Growth Rate

      • 10.1.2 Brazil Ophthalmology Drugs Market Volume and Growth Rate

      • 10.1.3 North Africa Ophthalmology Drugs Market Volume and Growth Rate

      • 10.1.4 South Africa Ophthalmology Drugs Market Volume and Growth Rate

      • 10.1.5 Argentina Ophthalmology Drugs Market Volume and Growth Rate

    11 Major Players Profiles

    • 11.1 Regeneron

      • 11.1.1 Regeneron Company Profile and Recent Development

      • 11.1.2 Market Performance

      • 11.1.3 Product and Service Introduction

    • 11.2 Roche

      • 11.2.1 Roche Company Profile and Recent Development

      • 11.2.2 Market Performance

      • 11.2.3 Product and Service Introduction

    • 11.3 Allergan

      • 11.3.1 Allergan Company Profile and Recent Development

      • 11.3.2 Market Performance

      • 11.3.3 Product and Service Introduction

    • 11.4 Shire

      • 11.4.1 Shire Company Profile and Recent Development

      • 11.4.2 Market Performance

      • 11.4.3 Product and Service Introduction

    • 11.5 Novartis

      • 11.5.1 Novartis Company Profile and Recent Development

      • 11.5.2 Market Performance

      • 11.5.3 Product and Service Introduction

    • 11.6 Mallinckrodt

      • 11.6.1 Mallinckrodt Company Profile and Recent Development

      • 11.6.2 Market Performance

      • 11.6.3 Product and Service Introduction

    • 11.7 Bayer

      • 11.7.1 Bayer Company Profile and Recent Development

      • 11.7.2 Market Performance

      • 11.7.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 88 Figures and 139 Tables)

    • Figure Product Picture

    • Figure Market Size and Growth Rate of Lucentis (ranibizumab)

    • Figure Market Size and Growth Rate of Eylea (aflibercept)

    • Figure Market Size and Growth Rate of Avastin (bevacizumab)

    • Figure Market Size and Growth Rate of Restasis (cyclosporine)

    • Figure Market Size and Growth Rate of Alphagan (brimonidine tartrate)

    • Figure Market Size and Growth Rate of Lumigan (bimatoprost)

    • Figure Market Size and Growth Rate of Xalatan (latanoprost

    • Figure Market Size and Growth Rate of Chorioretinitis

    • Figure Market Size and Growth Rate of Choroiditis

    • Figure Market Size and Growth Rate of Retinitis

    • Figure Market Size and Growth Rate of Others

    • Figure North America Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure United States Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Europe Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Germany Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure UK Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure France Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Asia-Pacific Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure China Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Japan Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Australia Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure India Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure ASEAN Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure South Korea Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure LAMEA Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure GCC Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Brazil Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure North Africa Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure South Africa Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Argentina Ophthalmology Drugs Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Ophthalmology Drugs Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Ophthalmology Drugs

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Ophthalmology Drugs by Different Types from 2014 to 2026

    • Table Consumption Share of Ophthalmology Drugs by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Lucentis (ranibizumab)

    • Figure Market Size and Growth Rate of Eylea (aflibercept)

    • Figure Market Size and Growth Rate of Avastin (bevacizumab)

    • Figure Market Size and Growth Rate of Restasis (cyclosporine)

    • Figure Market Size and Growth Rate of Alphagan (brimonidine tartrate)

    • Figure Market Size and Growth Rate of Lumigan (bimatoprost)

    • Figure Market Size and Growth Rate of Xalatan (latanoprost

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Ophthalmology Drugs by Different End-Users from 2014 to 2026

    • Table Consumption Share of Ophthalmology Drugs by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Chorioretinitis

    • Figure Market Size and Growth Rate of Choroiditis

    • Figure Market Size and Growth Rate of Retinitis

    • Figure Market Size and Growth Rate of Others

    • Table Global Ophthalmology Drugs Production by Major Regions

    • Table Global Ophthalmology Drugs Production Share by Major Regions

    • Table Global Ophthalmology Drugs Consumption by Major Regions

    • Table Global Ophthalmology Drugs Consumption Share by Major Regions

    • Table North America Ophthalmology Drugs Production, Import, Consumption and Export Analysis

    • Table Europe Ophthalmology Drugs Production, Import, Consumption and Export Analysis

    • Table Asia Pacific Ophthalmology Drugs Production, Import, Consumption and Export Analysis

    • Table LAMEA Ophthalmology Drugs Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Ophthalmology Drugs Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Ophthalmology Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Ophthalmology Drugs Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Ophthalmology Drugs Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table North America Ophthalmology Drugs Consumption by Major Countries from 2014 to 2026

    • Table North America Ophthalmology Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure North America Ophthalmology Drugs Consumption Share by Major Countries in 2014

    • Figure North America Ophthalmology Drugs Consumption Share by Major Countries in 2018

    • Figure North America Ophthalmology Drugs Consumption Share by Major Countries in 2026

    • Figure United States Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Canada Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Mexico Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Europe Ophthalmology Drugs Consumption by Types from 2014 to 2026

    • Table Europe Ophthalmology Drugs Consumption Share by Types from 2014 to 2026

    • Table Europe Ophthalmology Drugs Consumption by End-Users from 2014 to 2026

    • Table Europe Ophthalmology Drugs Consumption Share by End-Users from 2014 to 2026

    • Table Europe Ophthalmology Drugs Consumption by Major Countries from 2014 to 2026

    • Table Europe Ophthalmology Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure Germany Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure UK Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure France Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Italy Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Nordic Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Spain Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Belgium Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Poland Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Russia Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Turkey Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Portugal Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Denmark Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Asia Pacific Ophthalmology Drugs Consumption by Major Countries from 2014 to 2026

    • Table Asia Pacific Ophthalmology Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure China Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Japan Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Australia Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure India Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure ASEAN Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Korea Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Latin America, Middle East & Africa Ophthalmology Drugs Consumption by Major Countries from 2014 to 2026

    • Table Latin America, Middle East & Africa Ophthalmology Drugs Consumption Share by Major Countries from 2014 to 2026

    • Figure GCC Countries Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Brazil Countries Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure North Africa Countries Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure South Africa Countries Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Figure Argentina Countries Ophthalmology Drugs Market Volume and Growth Rate from 2014 to 2026

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Regeneron

    • Figure Sales and Growth Rate Analysis of Regeneron

    • Figure Revenue and Market Share Analysis of Regeneron

    • Table Product and Service Introduction of Regeneron

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche

    • Figure Sales and Growth Rate Analysis of Roche

    • Figure Revenue and Market Share Analysis of Roche

    • Table Product and Service Introduction of Roche

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Allergan

    • Figure Sales and Growth Rate Analysis of Allergan

    • Figure Revenue and Market Share Analysis of Allergan

    • Table Product and Service Introduction of Allergan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire

    • Figure Sales and Growth Rate Analysis of Shire

    • Figure Revenue and Market Share Analysis of Shire

    • Table Product and Service Introduction of Shire

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mallinckrodt

    • Figure Sales and Growth Rate Analysis of Mallinckrodt

    • Figure Revenue and Market Share Analysis of Mallinckrodt

    • Table Product and Service Introduction of Mallinckrodt

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer

    • Figure Sales and Growth Rate Analysis of Bayer

    • Figure Revenue and Market Share Analysis of Bayer

    • Table Product and Service Introduction of Bayer

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US